J Intercult Ethnopharmacol. 2016 Aug 17;5(4):439-443.
Ohkura N1, Oishi K2, Kihara-Negishi F3, Atsumi GI1, Tatefuji T4.
Author information
Abstract
BACKGROUND:
Brazilian propolis has many biological activities including the ability to help prevent thrombotic diseases, but this particular effect has not been proven. Plasma levels of plasminogen activator inhibitor-1 (PAI-1), an inhibitor of fibrinolysis, increase under inflammatory conditions such as infection, obesity and atherosclerosis and such elevated levels predispose individuals to a risk of developing thrombotic diseases.
AIM:
This study aimed to determine the effects of a diet containing Brazilian propolis on lipopolysaccharide (LPS)-induced increases in plasma PAI-1 levels.
MATERIALS AND METHODS:
Mice were fed with a diet containing 0.5% (w/w) Brazilian propolis for 8 weeks. Thereafter, the mice were subcutaneously injected with saline containing 0.015 mg/kg of LPS and sacrificed 4 h later.
RESULTS:
Orally administered Brazilian propolis significantly suppressed the LPS-induced increase in PAI-1 antigen and its activity in mouse plasma.
CONCLUSION:
This study indicated that Brazilian propolis contains natural products that can decrease thrombotic tendencies in mice.
PMID: 27757277 DOI: 10.5455/jice.20160814112735
[PubMed – in process]
* THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS IS NOT INTENDED TO DIAGNOSE, TREAT CURE OR PREVENT ANY DISEASE.